Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 57,840 shares at $19.72 ($1.1M) on 2021-04-15, disclosed to the SEC on 2021-04-16.
Open-market sale of $1.1M ALKS by EVP R&D, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.72 | 28,920 | $570K | 50.0% |
| 2 | $19.72 | 28,920 | $570K | 50.0% |
| Total | $19.72 avg | 57,840 | $1.1M | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |